Last Updated on January 14, 2024 by The Health Master
Oxford C-19 vaccine, Covishield, manufactured by the Serum Institute of India, will be sold to the Govt of India at Rs 200 per dose, SII head Adar Poonawalla told.
The vaccine will be sold at a higher price of Rs 1,000 per dose to private buyers.
The Oxford University-AstraZeneca vaccine was granted emergency authorisation by the Indian regulator on Sunday.
The authorization was granted on the condition that Serum Institute doesn’t export the shots, to ensure the safety of the vulnerable populations in India.
Watch the video for more:
Also read | Masks probably may never even go: ICMR
The Health Master is now on Telegram. For latest update on health and Pharmaceuticals, subscribe to The Health Master on Telegram.
Follow and connect with us on Facebook and Linkedin
Go to main website, click here
Subscribe for daily free updates, click here
